Published in
American Chemical Society, ACS Chemical Neuroscience, 10(10), p. 4350-4360, 2019
DOI: 10.1021/acschemneuro.9b00429
Links
Tools
Do Toxic Synthetic Cannabinoid Receptor Agonists Have Signature in Vitro Activity Profiles? A Case Study of AMB-FUBINACA
Journal article published in 2019 by
David B. Finlay 
,
Jamie J. Manning ,
Mikkel Søes Ibsen,
Christa E. Macdonald,
Monica Patel,
Jonathan A. Javitch,
Samuel D. Banister ,
Michelle Glass
,
Jamie J. Manning ,
Mikkel Søes Ibsen,
Christa E. Macdonald,
Monica Patel,
Jonathan A. Javitch,
Samuel D. Banister ,
Michelle Glass
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Preprint: archiving allowed
- Must obtain written permission from Editor
- Must not violate ACS ethical Guidelines
Postprint:
archiving restricted
- Must obtain written permission from Editor
- Must not violate ACS ethical Guidelines
Published version:
archiving forbidden
Data provided by 